EXG34217
Sponsors
Elixirgen Therapeutics, Inc.
Conditions
Bone Marrow FailureTelomere Biology Disorders With Bone Marrow FailureTelomere Shortening
Phase 1
Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure
Active, not recruitingNCT04211714
Start: 2021-04-08End: 2027-10-08Target: 12Updated: 2026-02-06
Rollover Study From EXG-US-01
Enrolling by invitationNCT05868499
Start: 2024-01-01End: 2027-01-30Target: 12Updated: 2024-07-12